| |
| |
|
| Insider
Information: |
Renton Hollings |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
91,099 |
|
|
Indirect Shares
|
113,469 |
|
|
| Direct
Value |
$44,636 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
204,568 |
|
|
| Total
Value |
$44,636 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
President and CEO, Dir... |
2007-02-21 |
89,149 |
2008-02-19 |
113,469 |
Premium* |
|
|
Cepheid |
CPHD |
Director |
2016-11-04 |
0 |
2005-11-30 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2020-07-02 |
0 |
Premium* |
|
|
Anaptysbio Inc |
ANAB |
|
2024-06-18 |
1,950 |
2024-06-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
160 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2019-11-01 |
4 |
AS |
$30.00 |
$150,000 |
D/D |
(5,000) |
13,194 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2019-11-01 |
4 |
OE |
$9.00 |
$45,000 |
D/D |
5,000 |
18,194 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,281 |
20,475 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2020-07-02 |
4 |
D |
$18.00 |
$131,058 |
D/D |
(7,281) |
0 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2011-02-17 |
4 |
S |
$24.82 |
$186,164 |
D/D |
(7,500) |
500 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2011-02-17 |
4 |
OE |
$7.35 |
$55,125 |
D/D |
7,500 |
8,000 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2012-02-06 |
4 |
OE |
$8.65 |
$64,875 |
D/D |
7,500 |
9,050 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President and CEO |
• • – |
2006-07-11 |
4 |
OE |
$7.63 |
$64,050 |
I/I |
8,400 |
23,648 |
|
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2014-11-07 |
4 |
OE |
$20.47 |
$191,906 |
D/D |
9,375 |
18,892 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2014-11-07 |
4 |
S |
$51.07 |
$478,781 |
D/D |
(9,375) |
9,517 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2015-02-25 |
4 |
OE |
$31.85 |
$298,594 |
D/D |
9,375 |
18,892 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2015-02-25 |
4 |
S |
$57.76 |
$541,509 |
D/D |
(9,375) |
9,517 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President and CEO |
• • – |
2003-11-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,000 |
134,889 |
|
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2015-05-11 |
4 |
S |
$38.33 |
$403,179 |
D/D |
(10,520) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2015-05-11 |
4 |
OE |
$7.00 |
$73,640 |
D/D |
10,520 |
10,520 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2016-11-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,567) |
0 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2011-07-27 |
4 |
OE |
$9.18 |
$114,750 |
D/D |
12,500 |
14,050 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2011-07-27 |
4 |
S |
$37.71 |
$471,415 |
D/D |
(12,500) |
1,550 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2012-02-03 |
4 |
S |
$43.20 |
$539,988 |
D/D |
(12,500) |
1,550 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2012-02-03 |
4 |
OE |
$11.85 |
$148,125 |
D/D |
12,500 |
14,050 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2013-11-08 |
4 |
OE |
$9.26 |
$115,750 |
D/D |
12,500 |
21,150 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2013-11-08 |
4 |
S |
$41.44 |
$517,939 |
D/D |
(12,500) |
8,650 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2014-10-20 |
4 |
S |
$45.83 |
$573,167 |
D/D |
(12,500) |
9,517 |
0 |
- |
|
| CPHD |
Cepheid |
Director |
– • – |
2014-10-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
22,017 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2020-07-02 |
4 |
D |
$18.00 |
$237,492 |
D/D |
(13,194) |
0 |
0 |
- |
|
160 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
